Archives for September 2015


This week’s fibromyalgia and ME/CFS news (week of Sept. 28, 2015)

Top stories ... This could be a huge breakthrough for the fibromyalgia community: "Neuroscientists at Georgetown University Medical Center and Germany's Technische Universität München say they've uncovered the brain malady responsible for tinnitus and for chronic pain," reports UK mom says HPV vaccine caused her daughter's CFS, reports the Ilford Recorder. Blogger Julie Ryan from explores why we doubt fibromyalgia and ME/CFS recovery stories. An attorney gives a simplified explanation of why 60+ Cymbalta withdrawal lawsuits have been moved to … [Read more...]


Quitting Cymbalta? What you need to know before you take that last pill

Note: "Quitting Cymbalta" is Part 1 in an ongoing series on Cymbalta's withdrawal symptoms. Part 2 includes an interview with Baum, Hedlund, Aristei & Goldman, PC, one of the law firms representing hundreds of patients who have been affected by Cymbalta's withdrawal symptoms. Part 3 is a timeline of the lawsuits and summarizes the cases that have been heard so far and their outcomes. As always, I'll post any news related to the lawsuits in my fibromyalgia news updates. To make things easy, I've created a page dedicated to the lawsuits where you'll find all of FedUpwithFatigue's … [Read more...]


This week’s fibromyalgia and ME/CFS news (week of September 21, 2015)

Top headlines ... "New draft guidelines by the [U.S.] Centers for Disease Control and Prevention (CDC) would – if adopted - sharply reduce the prescribing of opioids for both chronic and acute pain in the U.S.," reports Pain News Network. (This story may be alarming for anyone who takes opioids for pain.) Hemispherx Biopharma is now offering a Patient Assistance Program for the open-label AMP-511 study of Ampligen® in ME/CFS patients. The company recently announced Ampligen's first cost increase in 17 years. The Patient Assistance Program will enable patients in the open-label study to … [Read more...]


This week’s fibromyalgia and ME/CFS news (week of September 14, 2015)

Top stories ... Pfizer loses its legal bid to force UK physicians to prescribe Lyrica for neuropathic pain instead of cheaper generics. The decision opens the door to "cheap copycats" of the drug. Pfizer, of course, is appealing the court ruling. Here's a fun headline for you: "I couldn't get out of bed for eight months [due to ME] - Now I'm a burlesque stripper." According to the woman featured in this story from the Mirror (UK), she's lived a "normal life" for the past nine months ... thanks to burlesque dancing! I bet your friends never suggested THAT as a treatment! Fighting back: … [Read more...]


What you need to know about CBD oil and fibromyalgia

Updated 5/17/19 If you've spent much time in the fibromyalgia community lately, then you know there's quite a bit of interest in using CBD oil for fibromyalgia pain. And it's not hard to understand why. So many of us, myself included, haven't been able to find relief from pharmaceuticals, either because they just don't work or we can't take them due to side effects. If you've been reading this blog for a while, then you know I'm always up for trying new products that might improve my fibromyalgia symptoms. I know there's no cure for fibro, but I do believe there are products out … [Read more...]


This week’s fibromyalgia and ME/CFS news (week of September 7, 2015)

Top stories ... Japan's Ministry of Health, Labor and Welfare says drug-maker Pfizer failed to report hundreds of serious adverse reactions caused by Lyrica and other drugs. Griffith University (Australia) researchers find that critical cell receptors are damaged in ME/CFS patients. A 40mg generic version of Cymbalta is now available to patients in the United States. Thousands of patients left scrambling: Fear of prosecution prompts Montana (U.S.) doctor to stop prescribing opiates to fibromyalgia and other chronic pain patients. This heartbreaking tattoo reminds us that we aren't … [Read more...]


This week’s fibromyalgia and ME/CFS news (week of August 31, 2015)

Top stories ... More bad news for patients who are suing drug-maker Eli Lilly and Co. over Cymbalta's withdrawal symptoms: "A Virginia federal judge on Friday, [August 28], found that two women suing Eli Lilly and Co. for allegedly misrepresenting the withdrawal risks of its antidepressant drug Cymbalta had failed to present enough jury evidence to support their fraud claims...," according to Law360. Unfortunately, Law360 requires a paid subscription to read the rest of the article. (Sorry, I wasn't able to find a comparable story on free media.) Canadian man arrested after stealing … [Read more...]

Wordpress content guard plugin by